Private practice with Dr Seth BilazarianView all posts »
Where to from AIM-HIGH?Jun 3, 2011 10:40 EDT
Should we continue to pursue HDL therapy? Does the concept of treating for residual risk still make sense? Important questions are raised by the halting of the AIM-HIGH trial. As we await the trial data, how have you modified your clinical practice? What advice are you giving your patients?
Disclosure: I was a clinical investigator for AIM-HIGH